Revenue
$33.5B
▲ 3.6% YoY
Net Income
$4.7B
▲ 26.8% YoY
EPS
$3.61
▲ 30.8% YoY
Cash
$2.2B
▲ 72.7% YoY
FY 2025 · As of 2025-04-25
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Pieton Thierry EVP & Chief Financial Officer | Sell tax | Mar 3, 2026 | 3.0K | $96.71 | $288K | Form 4 ↗ |
Blomquist Denise L. Chief Accounting Officer | Gift | Feb 20, 2026 | 340 | $0.00 | $0 | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Vest | Feb 19, 2026 | 30.6K | $93.08 | $2.85M | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Vest | Feb 19, 2026 | 19.9K | $87.76 | $1.75M | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Vest | Feb 19, 2026 | 385 | $80.00 | $31K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Feb 19, 2026 | 1.6K | $97.86 | $161K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Feb 19, 2026 | 30.6K | $97.66 | $2.99M | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Feb 19, 2026 | 19.3K | $97.77 | $1.88M | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Feb 19, 2026 | 668 | $97.83 | $65K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Feb 19, 2026 | 385 | $97.82 | $38K | Form 4 ↗ |
Blomquist Denise L. Chief Accounting Officer | Sell tax | Jan 29, 2026 | 148 | $101.00 | $15K | Form 4 ↗ |